These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 38332160)
1. A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer. Song Z; Gui S; Xiao S; Rao X; Cong N; Deng H; Yu Z; Zeng T Sci Rep; 2024 Feb; 14(1):3198. PubMed ID: 38332160 [TBL] [Abstract][Full Text] [Related]
2. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. Zhu S; Zhao Q; Fan Y; Tang C BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825 [TBL] [Abstract][Full Text] [Related]
3. Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and Dong Y; Xu C; Su G; Li Y; Yan B; Liu Y; Yin T; Mou S; Mei H Front Immunol; 2023; 14():1122570. PubMed ID: 37275895 [TBL] [Abstract][Full Text] [Related]
4. Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target. Wang H; Liu J; Tang R; Hu J; Liu M; Wang J; Zhang J; Hou H Eur J Med Res; 2024 Jan; 29(1):52. PubMed ID: 38217031 [TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients. Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434 [TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of anoikis-related genes in bladder cancer: An observational study. Huang F; Zhou L; Sun J; Ma X; Pei Y; Zhang Q; Yu Y; He G; Zhu L; Li H; Wang X; Long F; Huang H; Zhang J; Sun X Medicine (Baltimore); 2024 Jul; 103(29):e38999. PubMed ID: 39029056 [TBL] [Abstract][Full Text] [Related]
7. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
8. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
10. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer. Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733 [TBL] [Abstract][Full Text] [Related]
11. Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma. Shen X; Xie J; Liu S; Cai Y; Yuan S; Uehara Y; Zhu D; Zheng M J Thorac Dis; 2024 Aug; 16(8):5361-5378. PubMed ID: 39268091 [TBL] [Abstract][Full Text] [Related]
12. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
13. Anoikis-related genes in breast cancer patients: reliable biomarker of prognosis. Tang M; Rong Y; Li X; Pan H; Tao P; Wu Z; Liu S; Tang R; Liu Z; Cai H BMC Cancer; 2024 Sep; 24(1):1163. PubMed ID: 39300389 [TBL] [Abstract][Full Text] [Related]
14. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma. Zhang X; Wen Z; Wang Q; Ren L; Zhao S Front Immunol; 2023; 14():1199869. PubMed ID: 37575253 [TBL] [Abstract][Full Text] [Related]
15. Multiple programmed cell death patterns and immune landscapes in bladder cancer: Evidence based on machine learning and multi-cohorts. Li Z; Li Y; Liu L; Zhang C; Li X Environ Toxicol; 2024 Mar; 39(3):1780-1801. PubMed ID: 38064272 [TBL] [Abstract][Full Text] [Related]
16. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. Chen F; Wang Q; Zhou Y BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma. Chen L; Lin J; Wen Y; Chen Y; Chen CB Front Oncol; 2023; 13():1291720. PubMed ID: 38023241 [TBL] [Abstract][Full Text] [Related]
20. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]